Literature DB >> 25211147

The natural history of spinal neurofibromatosis: a critical review of clinical and genetic features.

M Ruggieri1, A Polizzi, A Spalice, V Salpietro, R Caltabiano, V D'Orazi, P Pavone, C Pirrone, G Magro, N Platania, S Cavallaro, M Muglia, F Nicita.   

Abstract

Spinal neurofibromatosis (SNF) is a related form of neurofibromatosis 1 (NF1), characterized by bilateral neurofibromas (histologically proven) of all spinal roots (and, eventually, of all the major peripheral nerve branches) with or without other manifestations of classical NF1. By rigorous application of these criteria to the 98 SNF cases published, we developed: (i) a cohort of 49 SNF patients (21 males and 28 females; aged 4-74 years]: 9 SNF families (21/49), 1 mixed SNF/NF1 family (1/49) and 27 of 49 sporadic SNF patients (including 5 unpublished patients in this report); and (ii) a group of 49 non-SNF patients including: (a) 32 patients with neurofibromas of multiple but not all spinal roots (MNFSR): 4 mixed SNF/MNFSR families (6/32); (b) 14 patients with NF1 manifestations without spinal neurofibromas, belonging to SNF (8/49) or MNFSR families (6/32); (c) 3 patients with neurofibromas in one spinal root. In addition to reduced incidence of café-au-lait spots (67% in SNF vs 56% in MNFSR), other NF1 manifestations were less frequent in either cohort. Molecular testing showed common NF1 gene abnormalities in both groups. The risk of developing SNF vs NF1 was increased for missense mutations [p = 0.0001; odds ratio (OR) = 6.16; confidence interval (CI) = 3.14-13.11], which were more frequent in SNF vs MNFSR (p = 0.0271).
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  NF1; familial spinal neurofibromatosis; multiple neurofibromas; paraspinal neurofibromatosis; spinal neurofibromatosis

Mesh:

Year:  2014        PMID: 25211147     DOI: 10.1111/cge.12498

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  19 in total

1.  Identification of an atypical microdeletion generating the RNF135-SUZ12 chimeric gene and causing a position effect in an NF1 patient with overgrowth.

Authors:  Luca Ferrari; Giulietta Scuvera; Arianna Tucci; Donatella Bianchessi; Francesco Rusconi; Francesca Menni; Elena Battaglioli; Donatella Milani; Paola Riva
Journal:  Hum Genet       Date:  2017-08-03       Impact factor: 4.132

2.  Neurocutaneous melanocytosis (melanosis).

Authors:  Martino Ruggieri; Agata Polizzi; Stefano Catanzaro; Manuela Lo Bianco; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-10-13       Impact factor: 1.475

Review 3.  Spinal manifestations of Neurofibromatosis type 1.

Authors:  Ben Shofty; Ori Barzilai; Morsi Khashan; Zvi Lidar; Shlomi Constantini
Journal:  Childs Nerv Syst       Date:  2020-06-20       Impact factor: 1.475

4.  Introduction to phacomatoses (neurocutaneous disorders) in childhood.

Authors:  Martino Ruggieri; Agata Polizzi; Gioacchino Paolo Marceca; Stefano Catanzaro; Andrea D Praticò; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2020-09-17       Impact factor: 1.475

5.  Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report.

Authors:  Pamela Brock; Jean Bustamante Alvarez; Amir Mortazavi; Sameek Roychowdhury; John Phay; Raheela A Khawaja; Manisha H Shah; Bhavana Konda
Journal:  Fam Cancer       Date:  2020-04       Impact factor: 2.375

6.  Spinal and Paraspinal Plexiform Neurofibromas in Patients with Neurofibromatosis Type 1: A Novel Scoring System for Radiological-Clinical Correlation.

Authors:  M Mauda-Havakuk; B Shofty; S Ben-Shachar; L Ben-Sira; S Constantini; F Bokstein
Journal:  AJNR Am J Neuroradiol       Date:  2017-08-10       Impact factor: 3.825

7.  Molecular genetic evaluation of pediatric renovascular hypertension due to renal artery stenosis and abdominal aortic coarctation in neurofibromatosis type 1.

Authors:  Dawn M Coleman; Yu Wang; Min-Lee Yang; Kristina L Hunker; Isabelle Birt; Ingrid L Bergin; Jun Z Li; James C Stanley; Santhi K Ganesh
Journal:  Hum Mol Genet       Date:  2022-02-03       Impact factor: 5.121

Review 8.  Emerging genotype-phenotype relationships in patients with large NF1 deletions.

Authors:  Hildegard Kehrer-Sawatzki; Victor-Felix Mautner; David N Cooper
Journal:  Hum Genet       Date:  2017-02-17       Impact factor: 4.132

9.  The MEK inhibitor selumetinib reduces spinal neurofibroma burden in patients with NF1 and plexiform neurofibromas.

Authors:  Sadhana Jackson; Eva H Baker; Andrea M Gross; Patricia Whitcomb; Andrea Baldwin; Joanne Derdak; Cecilia Tibery; Jennifer Desanto; Amanda Carbonell; Kaleb Yohay; Geraldine O'Sullivan; Alice P Chen; Brigitte C Widemann; Eva Dombi
Journal:  Neurooncol Adv       Date:  2020-08-08

10.  Genotype-Phenotype Correlations in Neurofibromatosis and Their Potential Clinical Use.

Authors:  Chetan Bettegowda; Meena Upadhayaya; D Gareth Evans; AeRang Kim; Dimitrios Mathios; Clemens O Hanemann
Journal:  Neurology       Date:  2021-07-06       Impact factor: 11.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.